Literature DB >> 1923505

Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate.

Y M Chen1, P L Chen, N Arnaiz, D Goodrich, W H Lee.   

Abstract

The p53 gene has been found to be mutated in many different kinds of human cancers. In a previous study, expression of exogenous wild-type p53 in human osteosarcoma cells by retrovirus-mediated gene transfer resulted in marked enlargement of cell size, reduced growth rate in culture and loss of tumorigenicity in nude mice. Here we examine the effects of expression of wild-type or mutated p53 on human peripheral neuroepithelioma (PNET) A673 cells; these cells contained apparently normal alleles of the p53 gene but did not express a detectable quantity of p53 protein. Various characteristics of the p53-expressing cells were examined including morphology, growth rate, soft-agar colony formation, and tumorigenicity in nude mice. In contrast to osteosarcoma Saos-2 cells, expression of wild-type or mutant p53 protein in A673 cells had no effect on morphology or growth characteristics. However, clones expressing wild-type p53 protein had reduced ability to form colonies in soft agar and tumors in nude mice. To substantiate the genotype of wild-type p53-expressing cells, the proviral p53-encoding DNA of one cell clone was amplified by the polymerase chain reaction and sequenced. We concluded that expression of a single allele of the wild-type p53 gene was sufficient to suppress PNET A673 tumorigenicity but had no detectable effect on growth rate in culture.

Entities:  

Mesh:

Year:  1991        PMID: 1923505

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.

Authors:  D Ronen; Y Teitz; N Goldfinger; V Rotter
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

2.  Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein.

Authors:  O Foord; N Navot; V Rotter
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

Review 3.  Tumor suppressor genes in molecular medicine.

Authors:  F Hoppe-Seyler; K Butz
Journal:  Clin Investig       Date:  1994-08

4.  Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants.

Authors:  M G Rizzo; S Soddu; G Tibursi; B Calabretta; A Sacchi
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

5.  Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma.

Authors:  Y Sun; K Nakamura; E Wendel; N Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Hot-spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle.

Authors:  Y Chen; P L Chen; W H Lee
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

7.  Wild-type p53 is not a negative regulator of simian virus 40 DNA replication in infected monkey cells.

Authors:  A von der Weth; W Deppert
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Physical and biological characterization of a growth-inhibitory activity purified from the neuroepithelioma cell line A673.

Authors:  K Stam; A A Stewart; G Y Qu; K K Iwata; D Fenyö; B T Chait; D R Marshak; J D Haley
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

9.  Functional evidence for a second tumor suppressor gene on human chromosome 17.

Authors:  P Chen; N Ellmore; B E Weissman
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

10.  Aberrant DNA damage response and DNA repair pathway in high glucose conditions.

Authors:  Amy Zhong; Melissa Chang; Theresa Yu; Raymond Gau; Daniel J Riley; Yumay Chen; Phang-Lang Chen
Journal:  J Can Res Updates       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.